EAM
BMY.RT

Erste Asset Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Erste Asset Management’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,425,220
Closed -$3.29M – 519
2020
Q4 		$3.29M Buy
2,425,220
+500,000
+26% +$1.06M 0.09% 205
2020
Q3 		$4.12M Buy
1,925,220
+250,000
+15% +$714K 0.14% 165
2020
Q2 		$5.87M Hold
1,675,220
– – 0.23% 123
2020
Q1 		$5.78M Buy
1,675,220
+1,350,000
+415% +$4.45M 0.34% 89
2019
Q4 		$972K Buy
+325,220
New +$846K 0.04% 280

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Erste Asset Management's BMY.RT Position: Q1 2021 in Review

Erste Asset Management sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 2,425,220 shares — an estimated $3.29M sold.

Erste Asset Management first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $5.87M in Q2 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Erste Asset Management reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Erste Asset Management sold 2,425,220 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $3.29M.
  • Erste Asset Management first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Erste Asset Management's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $5.87M in Q2 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Erste Asset Management's 13F filing for Q1 2021, filed 25 Nov 2024.